More than 8 million Asians to be blinded by glaucoma in 2 years

Article

A survey, released by the global campaign, All Eyes on Glaucoma, has revealed that more than 8.4 million people in Asia will be blinded by glaucoma by 2010 if they do not undergo treatment.

A survey, released by the global campaign, All Eyes on Glaucoma, has revealed that more than 8.4 million people in Asia will be blinded by glaucoma by 2010 if they do not undergo treatment.

The survey, which interviewed 935 people across nine countries, including China and India, found that awareness levels were low amongst the population, with only 54% having heard of glaucoma.

Clement Tham, professor of ophthalmology at the Chinese University of Hong Kong admitted that Asians were more prone to glaucoma because their eyes are generally smaller than those of Westerners, which leads to higher pressure within the eye. Prin Rojanapongpun, an ophthalmology professor in Thailand, also blamed excessive use of over-the-counter steroid eye drops, which could lead to glaucoma, for the increase.

According to the survey, 9.4 million people aged 40 or over in China alone suffer from the disease and this figure is expected to increase by 6 million by 2020.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.